Vertex (VRTX) EVP/CMO Carmen Bozic Sells Shares

What Happened Carmen Bozic, EVP and Chief Medical Officer of Vertex Pharmaceuticals (VRTX), disposed of 1,354 shares in an open-market sale on 2026-05-15. The shares were sold at $453.45 each for a total transaction value of $613,971. This was a sale (not a purchase) and is typically considered routine insider selling.

Key Details

• Transaction date: 2026-05-15
• Price per share: $453.45; Total value: $613,971
• Transaction code: S (Sale) — open market or private sale reported as open market
• Filing date (Form 4): 2026-05-19 — filed within the SEC’s two-business-day window (timely)
• Footnote: Sale executed pursuant to a company-approved Rule 10b5-1 trading plan entered 11/20/2025 (prearranged plan)
• Shares owned after transaction: Not reported in the provided filing

Context A 10b5-1 plan lets insiders sell preplanned amounts on a set schedule and is commonly used to avoid concerns about trading on nonpublic information. Sales do not necessarily indicate negative views about the company; they can be for diversification, tax, or personal liquidity reasons. This filing appears routine and was reported on time.